Prevalence and factors associated with metabolic syndrome in people living with HIV in Parakou in 2016

Abstract

ARV treatment has improved the quality of life of PHAs, but at the same time the occurrence of complications including the metabolic syndrome. Objective: To study the prevalence of DM and associated factors in PHAs receiving ARV treatment and follow-up at the University Hospital Center of Borgou (CHUDB) in Parakou in 2016. Patients and Methods: A cross-sectional, descriptive and analytical study with a prospective collection of data from 1 February to 31 July 2016. A comprehensive recruitment of all PLHIVs of at least 15 years of age was followed at the CHDB and agreed to completion of the study. The metabolic syndrome was defined according to the criteria of the IDF. All patients received a biological check-up. Results: 215 PHAs were included; the sex ratio was 0.47; the average age: 43.65 ± 11.38 years. The metabolic syndrome was found in 39 patients (18.14%). Among the subjects surveyed, 33.02% were hypertensive. Abdominal obesity, according to IDF criteria was found in 24.19% of cases;the overweight and overall obesity were 28.37% and 09.20%, respectively. Dyslipidemia in 53.95% of cases with total hypercholesterolemia in 32.09% of cases, LDL hypercholesterolemia in 21.86% of cases, HDL hypocholesterolemia in 68.37% of cases and hypertriglyceridemia in 21.86% of cases. Metabolic syndrome was associated with female sex and overweight.